Peapack-Gladstone Financial Corp’s Guardant Health GH Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,000	Closed	-$300K	–	705
2021 Q4	$300K	Hold	3,000	–	–	0.01%	556
2021 Q3	$375K	Hold	3,000	–	–	0.01%	510
2021 Q2	$373K	Hold	3,000	–	–	0.01%	476
2021 Q1	$458K	Buy	+3,000	New	+$453K	0.01%	423

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Peapack-Gladstone Financial Corp's GH Position: Q1 2022 in Review

Peapack-Gladstone Financial Corp sold out of Guardant Health (GH) in Q1 2022, closing a stake of 3,000 shares — an estimated $300K sold.

Peapack-Gladstone Financial Corp first reported a position in GH in Q1 2021 and held it in 4 quarters. The position peaked at $458K in Q1 2021. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

Peapack-Gladstone Financial Corp reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
Peapack-Gladstone Financial Corp sold 3,000 Guardant Health shares in Q1 2022, an estimated $300K.
Peapack-Gladstone Financial Corp first reported a position in Guardant Health in Q1 2021 and held it in 4 quarters.
Peapack-Gladstone Financial Corp's Guardant Health position peaked at $458K in Q1 2021.
356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2022, filed 16 May 2022.